Lidocaine Hci Injection, Solution
Product Images NDC 51662-1461

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label Opt. 1 (Carton Opt 1)

Packaging label for Lidocaine HCl Injection, USP 1% (10 mg/mL), 5 mL single-dose syringe. The label indicates a total lidocaine content of 50 mg per syringe, preservative-free, marketed by Hospira, Inc. The label includes use instructions for a syringe, dosing information, and cautions for intravenous use in ventricular arrhythmias.*

FDA Label Image

Carton Label Opt. 2 (Carton Opt 2)

Packaging label for Lidocaine HCl Injection, USP 1% solution, 50 mg per 5 mL (10 mg/mL) in a single-dose 5 mL syringe. The label highlights intravenous use for ventricular arrhythmias and indicates the product is preservative free. Manufactured by Hospira, distributed by HF Acquisition Co LLC, DBA HealthFirst. Includes instructions for aseptic technique to prepare the injection.*

FDA Label Image

Description 1 (Description 1)

A data table showing concentrations and pH ranges of Lidocaine Hydrochloride for intravenous injection. It lists two volumes: 5 mL containing 100 mg at 20 mg/mL, and a single-dose 5 mL containing 50 mg at 10 mg/mL, both with a pH range of 5.0 to 7.0.*

FDA Label Image

How Supplied (How Supplied)

A data table presenting information on LIDOCAINE HCI injection solutions for direct intravenous use. It lists NDC numbers, container types (such as Ansy® plastic syringe and LifeShield® Abboject® syringe with Male Luer Lock Adapter and 20-gauge protected needle), concentrations of 1% (10 mg/mL) and 2% (20 mg/mL), volume size of 5 mL, and total milligrams per package (50 mg or 100 mg).*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Carton Labeling (Serialized Carton R)

Packaging label for Lidocaine HCl Injection, USP 1% (10 mg/mL) in a 5 mL single-dose syringe. The label indicates 50 mg total lidocaine per syringe, preservative free, for intravenous use in ventricular arrhythmias. The product is manufactured or distributed by HF Acquisition Co., LLC, DBA HealthFirst, with the Hospira logo also present. The lot number and expiration date are printed on the box.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of lidocaine hydrochloride monohydrate showing the aromatic ring with two methyl groups and the amide linkage to the diethylaminoethyl side chain.*

FDA Label Image

Syringe Label Opt. 1 (Syringe Label Opt 1)

Label for LIDOCAINE HCI Injection, USP 1% (10 mg/mL) with strength 50 mg/5 mL. This is an intravenous injection solution for ventricular arrhythmias, packaged as a 5 mL single-dose syringe. Labeler is HF Acquisition Co LLC, DBA HealthFirst, and the NDC is 51662-1461. The label includes dosing markings, lot number, and expiration date fields.*

FDA Label Image

Syringe Label Opt. 2 (Syringe Opt 2)

Label for LIDOCAINE HCI Injection, USP 1% solution (10 mg/mL), supplied in 5 mL single-dose syringes. The label states it contains 50 mg/5 mL and is for intravenous use. It is manufactured by Hospira, Inc., with NDC 0409-9137-05 and includes a lot number and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.